SECsense Logo

Abivax SA's December 2024 Form 6-K: Leadership Change and Resignation Announcement

$ABVX
Form 6-K
Filed on: 2024-12-23
Source
Abivax SA's December 2024 Form 6-K: Leadership Change and Resignation Announcement

Here are the key insights and information extracted from the provided section of the financial report (Form 6-K) for Abivax SA:

  1. Document Type: This is a Form 6-K report, indicating it is a report of a foreign private issuer filed with the SEC.
  2. Date of Report: The document is dated December 23, 2024, and pertains to events occurring in that month.
  3. Company Information:
  • Name: Abivax SA
  • Address: 7-11 boulevard Haussmann, 75009 Paris, France
  • Contact: +33 (0) 1 53 83 08 41
  1. Commission File Number: 001-41842
  2. Significant Event:
  • Resignation Announcement: Dr. Philippe Pouletty has resigned from the Board of Directors, effective December 31, 2024.
  • Reason for Resignation: The resignation was not due to any disagreements regarding the company's operations, policies, or practices.
  1. Exhibit Reference: The company published a press release regarding Dr. Pouletty's resignation, which is included as Exhibit 99.1 in this report.
  2. Signatory Information:
  • Signed by: Marc de Garidel
  • Position: Chief Executive Officer
  • Date of Signature: December 23, 2024

This information is crucial for investors and analysts as it highlights a leadership change within the company, the context of that change, and the company's commitment to transparency regarding its executive decisions.